Clinical Evaluation of a Tubal Selective Delivery System

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorOregon Health and Science University

About this trial

A single center study to evaluate the performance and optimize the design of a novel intrauterine catheter system intended as a nonsignificant risk medical device to aid in evaluating tubal patency as part of the initial diagnostic workup for infertility.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Literate in English

Able to understand and sign an IRB-approved informed consent form

Willing to complete a pre-procedure questionnaire

Regular menstrual cycles (24- 38 days)

Disqualifiers

Currently pregnant as confirmed by positive high-sensitivity urine pregnancy test

Currently using hormonal contraception. Must have at least one natural cycle (two menses) prior to participation if recently discontinued hormonal contraception.

Currently using an intrauterine device (IUD). Must discontinue at least 30 days prior to Visit 2

Allergy or hypersensitive to radio-opaque contrast, ExEm foam, both doxycycline and azithromycin (allergy to one not exclusionary if can take the alternative), or lidocaine

Trial design

Design model

Single group

Treatments tested in this trial

  • Tubal Selective Delivery System (TSDS)

    Device

    A novel tubal selective delivery catheter system for selective delivery of administered agents to the fallopian tubes without entry of any portion of the catheter into the tubes.

Treatment groups

12 Participants
are divided into 1 treatment group
Group A: Tubal Selective Delivery SystemExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Clinical performance of catheter during insertion of device

Clinician impression of catheter performance during insertion of device. Performance is categorized as one of three levels: excellent, acceptable, or fail. The number of participants in each category will be reported, with categories defined as: Excellent: Clinician can place the insertion tube transcervically without dilation, and advance the obturator to expand the device without the use of imaging guidance. Acceptable: Cervical dilation required, but easy to advance the obturator to expand the device without the use of imaging guidance Fail: Unable to place the insertion tube

Time frame
Immediately post-procedure within 30 minutes
2

Expansion of arms and dual catheters

Expansion of arms and dual catheters in the two uterine cornua. Performance is categorized as one of three levels: excellent, acceptable, or fail. The number of participants in each category will be reported, with categories defined as: Excellent: Arms extend into bilateral cornua following transcervical insertion after initial expansion. Ultrasound confirms extension but is not needed Acceptable: Ultrasound is required to position arms, but expansion is successful after one or two attempts. Fail: Clinician is unable to position arms into cornua.

Time frame
During procedure immediately following attempt to position device
3

Inflation of dual balloons

Inflation of the dual balloons. Performance is categorized as one of three levels: excellent, acceptable, or fail. The number of participants in each category will be reported, with categories defined as: Excellent: Inflation of the dual balloons on first attempt by the clinician with no leakage or bad connections. This is confirmed by ultrasound. Acceptable: Inflation requires more than one attempt but is ultimately successful. Fail: Clinician is unable to inflate balloons due to high pressure or subject pain.

Time frame
During procedure immediate following attempt to inflate balloons
4

Delivery of saline

Delivery of saline. Performance is categorized as one of three levels: excellent, acceptable, or fail. The number of participants in each category will be reported, with categories defined as: Excellent: Successful administration of saline at low pressure (confirmed by ultrasound) with no leakage or bad connections. Acceptable: Some leakage of saline, but clinician is able to observe flow in tubes. Fail: Clinician unable to administer saline due to high pressure/pain, leakage or bad connections.

Time frame
During procedure immediate following attempt to administer saline

Secondary outcomes

1

Tolerability and ease of use - Provider experience evaluation

The clinician placing the device will evaluate ease of use using a series of 100 mm visual analog scale (anchors: 0 extremely easy; 100 extremely difficult/impossible) to evaluate these questions: Was the device easy to insert transcervically? Was inflation of the balloons easy? Was deliver of saline easy? Was deliver of ExEm foam easy? Was removal easy?

Time frame
Immediately Post-procedure (within 30 minutes)
2

Tolerability and ease of use - Patient experience evaluation

Participants will indicate maximum level of pain experienced during study procedures using 100 mm visual analogue scale (VAS) at various time points. We will compare pain with placement, treatment, and removal to several baseline assessments. VAS scales: Baseline expectation of pain, baseline pain immediately following speculum placement, baseline pain immediately prior to placement, pain associated with insertion, pain associated with balloon inflation, pain associated with administration of saline, pain associated with administration of ExEm foam, pain associated with complete device removal, pain 15 minutes after completion of procedure, overall satisfaction with procedure, willingness to recommend procedure to a friend.

Time frame
Pre-procedure, during procedure, immediately post-procedure, 15 minutes post-procedure

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: